Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer

Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer

Abstract Introduction Cabazitaxel multiple rechallenges may be a treatment option in heavily pretreated patients with metastatic castration‐resistant prostate cancer (mCRPC) who had a good initial response to cabazitaxel and who are still fit to receive it. Our objective was to assess the efficacy a...

Full description

Bibliographic Details
Main Authors: Cedric Pobel, Edouard Auclin, Diego Teyssonneau, Brigitte Laguerre, Mathilde Cancel, Elouen Boughalem, Johanna Noel, Pierre Emmanuel Brachet, Denis Maillet, Philippe Barthelemy, Carole Helissey, Constance Thibault, Stéphane Oudard
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Cancer Medicine
Subjects:
prostate cancer
chemotherapy
metastasis
cancer management
urological oncology
Online Access:https://doi.org/10.1002/cam4.4172

Internet

https://doi.org/10.1002/cam4.4172

Similar Items